Skip to main content

Table 6 The associations between CASC16 polymorphisms and BMI of breast cancer patients (adjusted by age and BMI)

From: The association of CASC16 variants with breast Cancer risk in a northwest Chinese female population

SNPGenotype> 24 kg/m2≤ 24 kg/m2
Case/ControlOR (95% CI)pCase/ControlOR (95% CI)p
rs3803662A231/1441 462/3131 
G105/840.78 (0.55–1.11)0.167204/1650.84 (0.65–1.08)0.165
AA76/471 159/1011 
GA79/500.97 (0.58–1.61)0.899144/1110.83 (0.59–1.19)0.313
GG13/170.46 (0.20–1.04)0.06330/270.73 (0.41–1.30)0.287
GA + GG92/670.84(0.52–1.36)0.481174/1380.81 (0.58–1.14)0.230
rs4784227C231/1741 476/3611 
T103/521.49 (1.01–2.20)0.042180/1171.17 (0.89–1.53)0.263
CC77/651 172/1351 
TC77/441.49 (0.91–2.46)0.115132/911.13 (0.79–1.60)0.503
TT13/42.64 (0.82–8.54)0.10424/131.45 (0.71–2.95)0.308
TC + TT90/481.59(0.98–2.58)0.059156/1041.17 (0.83–1.63)0.366
rs45544231G271/1811 534/3831 
C65/470.92 (0.61–1.41)0.711132/970.98 (0.73–1.31)0.871
GG111/721 217/1541 
CG49/370.83 (0.49–1.40)0.481100/750.96 (0.67–1.38)0.817
CC8/50.98 (0.31–3.15)0.97916/111.07 (0.48–2.38)0.869
CG + CC57/420.85 (0.51–1.40)0.516116/860.97 (0.69–1.34)0.873
rs12922061C229/1751 478/3531 
T107/531.54 (1.05–2.26)0.026188/1271.09 (0.84–1.42)0.508
CC78/621 166/1291 
TC73/511.15 (0.70–1.88)0.581146/951.20 (0.85–1.70)0.306
TT17/113.41 (1.74–103.6)0.01321/161.01 (0.51–2.02)0.968
TC + TT90/521.39 (0.86–2.25)0.178167/1111.17 (0.84–1.64)0.351
rs3112612A271/1811 532/3821 
G65/470.92 (0.61–1.41)0.711132/980.97 (0.72–1.30)0.823
AA111/721 216/1541 
GA49/370.83 (0.49–1.40)0.481100/740.97 (0.68–1.40)0.887
GG8/50.98 (0.31–3.15)0.97916/120.99 (0.47–2.18)0.994
GA + GG57/420.85 (0.51–1.40)0.516116/860.98 (0.69–1.38)0.896
  1. p values were calculated by unconditional logistic regression adjusted by age and BMI; p < 0.05 indicates statistical significance
  2. Highlighted in bold indicates the significant association between SNPs and breast cancer risk